Friedreich Ataxia Genetic Evaluation
Analyzes the FXN gene for pathogenic variants and GAA repeat expansions associated with Friedreich Ataxia (FA) to support accurate diagnosis and clinical evaluation.
Accessed through the FA Identified Sponsored Testing Program•Sponsored by Biogen•Performed by Prevention Genetics
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
FA Identified is a Biogen-sponsored program providing no-cost Friedreich ataxia genetic evaluation through Prevention Genetics. The program supports diagnostic confirmation or evaluation in patients with a clinical suspicion of FA, removing financial barriers to definitive genetic testing. Ordering carries no prescribing or purchase obligation.
When to consider this test
Patient selection
- To qualify, all of the following must be met:
- Patient resides within the US or Puerto Rico
- Patient is suspected of, or has a clinical diagnosis of, Friedreich Ataxia
- Patient is 16 years of age or older
Workflow
How to use this program
- 1
Assess Eligibility
Confirm the patient meets program criteria and discuss the purpose, benefits, and limitations of FA genetic testing.
- 2
Order the Test
Submit the order using the test requisition form (TRF). Ensure all required clinical and patient information is complete.
- 3
Collect and Label Specimen
Collect the specimen in the appropriate tube and label with at least two identifiers. Specimens are accepted Monday–Saturday; holiday schedules are posted online.
- 4
Review Results With Patient
Results are returned in about three weeks after the lab receives the specimen and paperwork. Discuss findings with the patient and caregiver as appropriate.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Prevention Genetics, a CLIA-certified laboratory (CLIA 52D2065132) and College of American Pathologists (CAP) certified laboratory (CAP 7185561). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
Which patients are appropriate candidates for the FA Identified Friedreich ataxia genetic testing program?
The FA Identified program is intended for patients with a suspected or clinical diagnosis of Friedreich ataxia who meet the program's eligibility criteria. Testing must be ordered by a qualified healthcare provider. Candidates must reside in the United States or Puerto Rico.
What does the FA Identified Friedreich ataxia genetic evaluation cover?
The FA Identified program provides a Friedreich Ataxia Genetic Evaluation that includes analysis of the FXN gene using next-generation sequencing (NGS). The test is performed by Prevention Genetics, a CAP/CLIA-certified laboratory. This evaluation can support diagnostic confirmation in patients with a clinical picture consistent with FA.
What specimen types are accepted for the FA Identified Friedreich ataxia test?
The FA Identified program accepts whole blood, saliva, or buccal swab specimens. Sample collection kits are provided to the ordering clinician at no charge. Kits can be ordered directly through Prevention Genetics.
What is the turnaround time for FA Identified Friedreich ataxia genetic testing results?
Results from the FA Identified Friedreich Ataxia Genetic Evaluation are typically returned within 2 to 3 weeks of specimen receipt at Prevention Genetics. Results are reported to the ordering provider.
Is there any cost or prescribing obligation when ordering through the FA Identified program?
There is no cost to the patient or the ordering provider for testing through FA Identified. Biogen sponsors the program and covers all testing costs. Ordering does not create any prescribing or purchase obligation for the clinician.
How do I order the FA Identified no-cost Friedreich ataxia genetic test for my patient?
Clinicians can order the FA Identified Friedreich Ataxia Genetic Evaluation through Prevention Genetics. A sample collection kit is shipped to your practice at no charge after placing the order. The test is listed under test code 20060 at Prevention Genetics and is New York State approved.
Which patients are eligible for FA Identified Friedreich Ataxia genetic testing?
Patients may qualify for FA Identified if they meet the program's eligibility criteria:
- Age: Patient is ≥16 years old.
- Location: Patient resides in the United States or Puerto Rico.
- Clinical criteria: Patient has a suspected or confirmed diagnosis of Friedreich Ataxia (FA).
- Ordering requirements: Testing must be ordered by a licensed health care professional.
See an issue with this program?